Predictive testing for Huntington's disease with use of a linked DNA marker
- PMID: 2893260
- DOI: 10.1056/NEJM198803033180903
Predictive testing for Huntington's disease with use of a linked DNA marker
Abstract
The probability of carrying the gene for Huntington's disease can in many cases be estimated in the children of affected persons by identifying a specific DNA marker that is genetically linked to the gene. We studied 47 persons at 50 percent risk of inheriting Huntington's disease who requested a presymptomatic or prenatal genetic-linkage test between September 1986 and January 1988. The participants were given pre-test counseling and psychological and neurologic evaluations. Nineteen persons later voluntarily withdrew from the protocol, including one who would have been excluded anyway, and one person was from a family that was too small to allow testing. Three D4S10 restriction-fragment-length polymorphisms produced by the HindIII, EcoRI, and Bg/I enzymes were used for all tests, and the probability that a subject was a Huntington's disease carrier was calculated. The accuracy of the test was compromised by a 4 percent recombination frequency between D4S10 and the Huntington's disease gene. Fifteen presymptomatic tests and one prenatal test were completed. Four yielded positive results, seven yielded negative results, and five were uninformative; seven persons are awaiting test results. All participants with positive tests experienced intermittent depression, but none required hospitalization, and no suicide threats were reported. Five participants received a diagnosis of Huntington's disease on the basis of the neurologic assessment. We conclude that some persons in the early stages of Huntington's disease may seek presymptomatic testing rather than neurologic evaluations.
Similar articles
-
[Psychosocial consequences of presymptomatic genetic testing. A retrospective study of testing for Huntington disease].Tidsskr Nor Laegeforen. 1999 May 20;119(13):1913-6. Tidsskr Nor Laegeforen. 1999. PMID: 10382341 Norwegian.
-
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.N Engl J Med. 1992 Nov 12;327(20):1401-5. doi: 10.1056/NEJM199211123272001. N Engl J Med. 1992. PMID: 1406858
-
A highly polymorphic locus very tightly linked to the Huntington's disease gene.Nature. 1988 Apr 21;332(6166):734-6. doi: 10.1038/332734a0. Nature. 1988. PMID: 2895895
-
Issues related to DNA testing for Huntington's disease in symptomatic patients.Semin Neurol. 1997;17(3):235-8. doi: 10.1055/s-2008-1040934. Semin Neurol. 1997. PMID: 9311065 Review.
-
[Predictive testing: presymptomatic diagnosis in neurogenetic disorders].Med Sci (Paris). 2005 Nov;21(11):934-9. doi: 10.1051/medsci/20052111934. Med Sci (Paris). 2005. PMID: 16274644 Review. French.
Cited by
-
The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.J Genet Couns. 2006 Oct;15(5):375-91. doi: 10.1007/s10897-006-9033-8. Epub 2006 Sep 27. J Genet Couns. 2006. PMID: 17004133
-
Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease.J Med Genet. 1995 Jul;32(7):516-8. doi: 10.1136/jmg.32.7.516. J Med Genet. 1995. PMID: 7562962 Free PMC article.
-
The paradigm of Huntington disease.Am J Hum Genet. 1989 Jul;45(1):169-75. Am J Hum Genet. 1989. PMID: 2525874 Free PMC article.
-
Exclusion testing in pregnancy for Huntington's disease.J Med Genet. 1990 Aug;27(8):488-95. doi: 10.1136/jmg.27.8.488. J Med Genet. 1990. PMID: 2145437 Free PMC article.
-
Mapping of D4S98/S114/S113 confines the Huntington's defect to a reduced physical region at the telomere of chromosome 4.Nucleic Acids Res. 1988 Dec 23;16(24):11769-80. doi: 10.1093/nar/16.24.11769. Nucleic Acids Res. 1988. PMID: 2905444 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical